WEST LAFAYETTE, Ind. – Vancomycin-resistant enterococcus (VRE) is among the leading causes of hospital-acquired infections in the United States. An estimated 20,000 people in the U.S. become infected ...
A drug-resistant strain of bacteria inhabiting hospital settings has evolved to utilize an antimicrobial genetic tool. Vancomycin-resistant Enterococcus faecium (VREfm) is responsible for many lethal ...
V-161, a novel compound targeting the Na+ -V-ATPase enzyme in vancomycin-resistant Enterococcus faecium (VRE), significantly reduces bacterial growth and colonization. A recent study has demonstrated ...
The scientists replaced a single atom from the molecular structure of vancomycin aglycon, a glycopeptide antibiotic that attacks the bacteria by inhibiting cell wall synthesis, significantly ...
Antibiotic resistance is a major concern, particularly for immunocompromised patients, who are at greater risk of serious infections. Microbiota composition can help prevent pathogenic bacteria from ...
The incidence of enterococcal infections has been increasing over the past few years, with rising rates of multidrug resistance. VRE is increasingly a problem in many hospitals and intensive care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results